Why the study?
Does cardiac troponin testing improve the detection of myocardial injury in animals compared to traditional biomarkers?
Does cardiac troponin testing improve the detection of myocardial injury in animals compared to traditional biomarkers?
Cardiac troponins I and T are highly sensitive and specific biomarkers for diagnosing myocardial injury in veterinary medicine, offering a wider diagnostic window than traditional enzymes.
Answers are grounded in this paper and cite their sources.
May aid myocardial injury detection in animals via prolonged elevation; leaves open need for prospective trials versus traditional biomarkers.
Analysis of cardiac troponin I (cTn I) and T (cTnT) are considered the "gold standard" for the non-invasive diagnosis of myocardial injury in human and animals. It has replaced traditionally used cardiac biomarkers such as myoglobin, lactate dehydrogenase (LDH), creatine kinase (CK) and CK-MB due to its high sensitivity and specificity for the detection of myocardial injury. Cardiac troponins are proteins that control the calcium-mediated interaction between actin and myosin, allowing contraction at the sarcomere level. Concentration of the cTn can be correlated microscopic lesion and loss of immunolabeling in myocardium damage. Troponin concentration remains elevated in blood for 1-2wks so that wide window is available for diagnosis of myocardial damage. The cTn test has >95% specificity and sensitivity and test is less time consuming (10 to 15 minutes) and less costly (INR 200 to INR 500).
No takes yet. Share an insight, caveat, or question.
Undhad et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: